Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder

被引：7

作者：

Fontenelle, LF

Mendlowicz, MV

Miguel, EC

Versiani, M

机构：

[1] IPUB UFRJ, Inst Psychiat, Anxiety & Depress Res Program, Rio De Janeiro, Brazil

[2] IPUB UFRJ, Inst Psychiat, Ethics & Forens Psychiat Res Program, Rio De Janeiro, Brazil

[3] UFF, MSM, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil

[4] USP, Sch Med, Obsess Compuls Spectrum Disorders Clin PROTOG, Dept Psychiat, BR-09500900 Sao Paulo, Brazil

来源：

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY | 2005年 / 6卷 / 01期

关键词：

obsessive-compulsive disorder; citalopram; reboxetine;

D O I：

10.1080/15622970510029740

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

While serotonin reuptake inhibitors (SRIs) are the first-line treatment of obsessive-compulsive disorder (OCD), as many as 40-60% of patients fail to respond to adequate trials with these drugs. In this study, we describe the case of a patient with an SRI-resistant OCD who was successfully treated with a combination of citalopram (a selective SRI) and reboxetine (a selective noradrenaline reuptake inhibitor (SNRI)). This report suggests that future studies accessing the efficacy of the SRI-SNRI combination in treatment resistant OCD are needed.

引用

页码：57 / 59

页数：3

共 50 条

[31] Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report
Kocamer Sahin, Senguel
Demir, Bahadir
Altindag, Abdurrahman
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (04) : 273 - 274
[32] Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
Swierkosz-Lenart, Kevin
Dos Santos, Joao Flores Alves
Elowe, Julien
Clair, Anne-Helene
Bally, Julien F.
Riquier, Francoise
Bloch, Jocelyne
Draganski, Bogdan
Clerc, Marie-Therese
Moyano, Beatriz Pozuelo
von Gunten, Armin
Mallet, Luc
FRONTIERS IN PSYCHIATRY, 2023, 14
[33] Ventral targeted anterior capsulotomy for treatment-resistant depression and obsessive-compulsive disorder: A treatment method with cases
Hurwitz, Trevor A.
Avecillas-Chasin, Josue M.
Bogod, Nicholas M.
Honey, Christopher R.
JOURNAL OF AFFECTIVE DISORDERS, 2024, 350 : 887 - 894
[34] EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)
Sayyah, Mehdi
Sayyah, Mohammad
Boostani, Hatam
Ghaffari, Seyyed Mohammad
Hoseini, Abedin
DEPRESSION AND ANXIETY, 2012, 29 (10) : 850 - 854
[35] The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder
Moon, Woori
Kim, Sung Nyun
Park, Sangmin
Paek, Sun Ha
Kwon, Jun Soo
MEDICINE, 2017, 96 (27)
[36] A systematic review of cognitive-behavioral therapy for pharmacotherapy treatment-resistant obsessive-compulsive disorder
Sijercic, Iris
Whitfield, Kristen M.
Cassin, Stephanie E.
Antony, Martin M.
JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2020, 26
[37] SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)
Pogarell, O
Poepperl, G
Mulert, C
Hamann, C
Sadowsky, N
Riedel, M
Moeller, HJ
Hegerl, U
Tatsch, K
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (05) : 521 - 524
[38] Modified Cognitive Behavior Therapy for Severe, Treatment-Resistant Obsessive-Compulsive Disorder in an Adolescent With Autism Spectrum Disorder
Krebs, Georgina
Murray, Kim
Jassi, Amita
JOURNAL OF CLINICAL PSYCHOLOGY, 2016, 72 (11) : 1162 - 1173
[39] Management of treatment resistant obsessive-compulsive disorder - Algorithms for pharmacotherapy
Albert, U
Bergesio, C
Pessina, E
Maina, G
Bogetto, F
PANMINERVA MEDICA, 2002, 44 (02) : 83 - 91
[40] A Review of Current Strategies for Treatment Resistant Obsessive-Compulsive Disorder
Maina, Giuseppe
Albert, Umberto
Salvi, Virginio
Bogetto, Filippo
CURRENT DRUG THERAPY, 2008, 3 (02) : 126 - 142

← 1 2 3 4 5 →